156 related articles for article (PubMed ID: 20824708)
1. Affinity-matured anti-glycoprotein NMB recombinant immunotoxins targeting malignant gliomas and melanomas.
Kuan CT; Wakiya K; Keir ST; Li J; Herndon JE; Pastan I; Bigner DD
Int J Cancer; 2011 Jul; 129(1):111-21. PubMed ID: 20824708
[TBL] [Abstract][Full Text] [Related]
2. Targeting IL-13Ralpha2-positive cancer with a novel recombinant immunotoxin composed of a single-chain antibody and mutated Pseudomonas exotoxin.
Kioi M; Seetharam S; Puri RK
Mol Cancer Ther; 2008 Jun; 7(6):1579-87. PubMed ID: 18566228
[TBL] [Abstract][Full Text] [Related]
3. Affinity-matured recombinant immunotoxin targeting gangliosides 3'-isoLM1 and 3',6'-isoLD1 on malignant gliomas.
Piao H; Kuan CT; Chandramohan V; Keir ST; Pegram CN; Bao X; Månsson JE; Pastan IH; Bigner DD
MAbs; 2013; 5(5):748-62. PubMed ID: 23924792
[TBL] [Abstract][Full Text] [Related]
4. Isolation of new anti-CD30 scFvs from DNA-immunized mice by phage display and biologic activity of recombinant immunotoxins produced by fusion with truncated pseudomonas exotoxin.
Rozemuller H; Chowdhury PS; Pastan I; Kreitman RJ
Int J Cancer; 2001 Jun; 92(6):861-70. PubMed ID: 11351308
[TBL] [Abstract][Full Text] [Related]
5. Immunotoxins with increased activity against epidermal growth factor receptor vIII-expressing cells produced by antibody phage display.
Beers R; Chowdhury P; Bigner D; Pastan I
Clin Cancer Res; 2000 Jul; 6(7):2835-43. PubMed ID: 10914732
[TBL] [Abstract][Full Text] [Related]
6. An anti-CD30 single-chain Fv selected by phage display and fused to Pseudomonas exotoxin A (Ki-4(scFv)-ETA') is a potent immunotoxin against a Hodgkin-derived cell line.
Klimka A; Barth S; Matthey B; Roovers RC; Lemke H; Hansen H; Arends JW; Diehl V; Hoogenboom HR; Engert A
Br J Cancer; 1999 Jun; 80(8):1214-22. PubMed ID: 10376974
[TBL] [Abstract][Full Text] [Related]
7. Improved cytotoxic activity toward cell lines and fresh leukemia cells of a mutant anti-CD22 immunotoxin obtained by antibody phage display.
Salvatore G; Beers R; Margulies I; Kreitman RJ; Pastan I
Clin Cancer Res; 2002 Apr; 8(4):995-1002. PubMed ID: 11948105
[TBL] [Abstract][Full Text] [Related]
8. Specific killing of HIV-infected lymphocytes by a recombinant immunotoxin directed against the HIV-1 envelope glycoprotein.
Bera TK; Kennedy PE; Berger EA; Barbas CF; Pastan I
Mol Med; 1998 Jun; 4(6):384-91. PubMed ID: 10780881
[TBL] [Abstract][Full Text] [Related]
9. A novel Carcinoembryonic Antigen (CEA)-Targeted Trimeric Immunotoxin shows significantly enhanced Antitumor Activity in Human Colorectal Cancer Xenografts.
Lázaro-Gorines R; Ruiz-de-la-Herrán J; Navarro R; Sanz L; Álvarez-Vallina L; Martínez-Del-Pozo A; Gavilanes JG; Lacadena J
Sci Rep; 2019 Aug; 9(1):11680. PubMed ID: 31406218
[TBL] [Abstract][Full Text] [Related]
10. Increased binding affinity enhances targeting of glioma xenografts by EGFRvIII-specific scFv.
Kuan CT; Wikstrand CJ; Archer G; Beers R; Pastan I; Zalutsky MR; Bigner DD
Int J Cancer; 2000 Dec; 88(6):962-9. PubMed ID: 11093822
[TBL] [Abstract][Full Text] [Related]
11. Glycoprotein nonmetastatic melanoma protein B, a potential molecular therapeutic target in patients with glioblastoma multiforme.
Kuan CT; Wakiya K; Dowell JM; Herndon JE; Reardon DA; Graner MW; Riggins GJ; Wikstrand CJ; Bigner DD
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):1970-82. PubMed ID: 16609006
[TBL] [Abstract][Full Text] [Related]
12. Comparison of recombinant immunotoxins against LeY antigen expressing tumor cells: influence of affinity, size, and stability.
Bera TK; Pastan I
Bioconjug Chem; 1998; 9(6):736-43. PubMed ID: 9815167
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity and pharmacokinetics in mice of a recombinant immunotoxin containing a disulfide-stabilized Fv fragment.
Reiter Y; Pai LH; Brinkmann U; Wang QC; Pastan I
Cancer Res; 1994 May; 54(10):2714-8. PubMed ID: 8168102
[TBL] [Abstract][Full Text] [Related]
14. Recombinant immunotoxins specific for a mutant epidermal growth factor receptor: targeting with a single chain antibody variable domain isolated by phage display.
Lorimer IA; Keppler-Hafkemeyer A; Beers RA; Pegram CN; Bigner DD; Pastan I
Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14815-20. PubMed ID: 8962138
[TBL] [Abstract][Full Text] [Related]
15. Selection of novel affinity-matured human chondroitin sulfate proteoglycan 4 antibody fragments by yeast display.
Yu X; Qu L; Bigner DD; Chandramohan V
Protein Eng Des Sel; 2017 Sep; 30(9):639-647. PubMed ID: 28981720
[TBL] [Abstract][Full Text] [Related]
16. Interstitial infusion of glioma-targeted recombinant immunotoxin 8H9scFv-PE38.
Luther N; Cheung NK; Souliopoulos EP; Karampelas I; Bassiri D; Edgar MA; Guo HF; Pastan I; Gutin PH; Souweidane MM
Mol Cancer Ther; 2010 Apr; 9(4):1039-46. PubMed ID: 20371725
[TBL] [Abstract][Full Text] [Related]
17. Phage display-based on-slide selection of tumor-specific antibodies on formalin-fixed paraffin-embedded human tissue biopsies.
Ten Haaf A; Pscherer S; Fries K; Barth S; Gattenlöhner S; Tur MK
Immunol Lett; 2015 Aug; 166(2):65-78. PubMed ID: 26045318
[TBL] [Abstract][Full Text] [Related]
18. The recombinant anti-EGF receptor immunotoxin 425(scFv)-ETA' suppresses growth of a highly metastatic pancreatic carcinoma cell line.
Bruell D; Stöcker M; Huhn M; Redding N; Küpper M; Schumacher P; Paetz A; Bruns CJ; Haisma HJ; Fischer R; Finnern R; Barth S
Int J Oncol; 2003 Oct; 23(4):1179-86. PubMed ID: 12964002
[TBL] [Abstract][Full Text] [Related]
19. Selection and characterization of human anti-MAGE-A1 scFv and immunotoxin.
Lin H; Mao Y; Zhang DW; Li H; Qiu JR; Zhu J; Chen RJ
Anticancer Agents Med Chem; 2013 Oct; 13(8):1259-66. PubMed ID: 23343082
[TBL] [Abstract][Full Text] [Related]
20. Isolation of a high-affinity stable single-chain Fv specific for mesothelin from DNA-immunized mice by phage display and construction of a recombinant immunotoxin with anti-tumor activity.
Chowdhury PS; Viner JL; Beers R; Pastan I
Proc Natl Acad Sci U S A; 1998 Jan; 95(2):669-74. PubMed ID: 9435250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
